Eleanor M Simonsick1, Chee W Chia2, Jennifer S Mammen3, Josephine M Egan2, Luigi Ferrucci2. 1. Intramural Research Program, National Institute on Aging, Baltimore, Maryland. Johns Hopkins University School of Medicine, Baltimore, Maryland. simonsickel@mail.nih.gov. 2. Intramural Research Program, National Institute on Aging, Baltimore, Maryland. Johns Hopkins University School of Medicine, Baltimore, Maryland. 3. Johns Hopkins University School of Medicine, Baltimore, Maryland.
Abstract
BACKGROUND: Emerging evidence suggests that mildly down-regulated thyroid function in older persons may protect and/or reflect maintained health. METHODS: Using observational data collected between January 2006 and March 2014 on a volunteer sample of 602 men and women aged 68-97 years with normal thyroid function participating in the Baltimore Longitudinal Study of Aging, this study examines the concurrent relationship between reported walking ability, usual and rapid gait speed, endurance walk performance, fatigability, and reported energy level with respect to free thyroxine (FT4) within the normal range (0.76-1.50ng/dL) as a continuous variable and categorized as low (lower quartile), medium (interquartile), or high (upper quartile). RESULTS: Adjusting for sex, age, race, height, weight, exercise and smoking, reported walking ability, usual and rapid gait speed, 400-m time, fatigability, and reported energy level were less favorable with increasing FT4 (p = .013 to <.001). In sex-strata, similar associations were observed except for walking ability in men and energy level in women. Categorical analyses revealed that persons with low FT4 exhibited better functional mobility, fitness, and reported energy than persons with intermediate or high levels (p < .05 for all). Persons with high-normal versus medium FT4 had slower usual and rapid gait speed (p < .05) only. CONCLUSION: Older adults with low-normal FT4 exhibit better mobility, fitness, and fatigue profiles. Mildly down-regulated thyroid function appears to align with better function in old age and may serve as a biomarker of healthy longevity. Published by Oxford University Press on behalf of the Gerontological Society of America 2016.
BACKGROUND: Emerging evidence suggests that mildly down-regulated thyroid function in older persons may protect and/or reflect maintained health. METHODS: Using observational data collected between January 2006 and March 2014 on a volunteer sample of 602 men and women aged 68-97 years with normal thyroid function participating in the Baltimore Longitudinal Study of Aging, this study examines the concurrent relationship between reported walking ability, usual and rapid gait speed, endurance walk performance, fatigability, and reported energy level with respect to free thyroxine (FT4) within the normal range (0.76-1.50ng/dL) as a continuous variable and categorized as low (lower quartile), medium (interquartile), or high (upper quartile). RESULTS: Adjusting for sex, age, race, height, weight, exercise and smoking, reported walking ability, usual and rapid gait speed, 400-m time, fatigability, and reported energy level were less favorable with increasing FT4 (p = .013 to <.001). In sex-strata, similar associations were observed except for walking ability in men and energy level in women. Categorical analyses revealed that persons with low FT4 exhibited better functional mobility, fitness, and reported energy than persons with intermediate or high levels (p < .05 for all). Persons with high-normal versus medium FT4 had slower usual and rapid gait speed (p < .05) only. CONCLUSION: Older adults with low-normal FT4 exhibit better mobility, fitness, and fatigue profiles. Mildly down-regulated thyroid function appears to align with better function in old age and may serve as a biomarker of healthy longevity. Published by Oxford University Press on behalf of the Gerontological Society of America 2016.
Entities:
Keywords:
Aging; Fatigue; Fitness; Free thyroxine; Physical function
Authors: Annewieke W van den Beld; Theo J Visser; Richard A Feelders; Diederick E Grobbee; Steven W J Lamberts Journal: J Clin Endocrinol Metab Date: 2005-09-20 Impact factor: 5.958
Authors: Bu B Yeap; Helman Alfonso; S A Paul Chubb; Gaurav Puri; Graeme J Hankey; Leon Flicker; Osvaldo P Almeida Journal: J Clin Endocrinol Metab Date: 2012-09-13 Impact factor: 5.958
Authors: Eleanor M Simonsick; Anne B Newman; Luigi Ferrucci; Suzanne Satterfield; Tamara B Harris; Nicolas Rodondi; Douglas C Bauer Journal: Arch Intern Med Date: 2009-11-23
Authors: Annewieke W van den Beld; Jean-Marc Kaufman; M Carola Zillikens; Steven W J Lamberts; Josephine M Egan; Aart J van der Lely Journal: Lancet Diabetes Endocrinol Date: 2018-07-17 Impact factor: 32.069
Authors: Katherine S Hall; Harvey J Cohen; Carl F Pieper; Gerda G Fillenbaum; William E Kraus; Kim M Huffman; Melissa A Cornish; Andrew Shiloh; Christy Flynn; Richard Sloane; L Kristin Newby; Miriam C Morey Journal: J Gerontol A Biol Sci Med Sci Date: 2017-04-01 Impact factor: 6.053
Authors: Simon H S Pearce; Salman Razvi; Mohammad E Yadegarfar; Carmen Martin-Ruiz; Andrew Kingston; Joanna Collerton; Theo J Visser; Tom B Kirkwood; Carol Jagger Journal: J Clin Endocrinol Metab Date: 2016-08-23 Impact factor: 5.958
Authors: Enoch J Abbey; John McGready; Lori J Sokoll; Eleanor M Simonsick; Jennifer S R Mammen Journal: Front Endocrinol (Lausanne) Date: 2022-03-04 Impact factor: 5.555
Authors: Arjola Bano; Layal Chaker; Sirwan K L Darweesh; Tim I M Korevaar; Francesco U S Mattace-Raso; Abbas Dehghan; Oscar H Franco; Jos N van der Geest; M Arfan Ikram; Robin P Peeters Journal: Sci Rep Date: 2016-12-14 Impact factor: 4.379